Exhibit 10(a)

AMENDMENT NO. 2 TO CREDIT AGREEMENT

AMENDMENT dated as of February 28, 2003 to the Five-Year Credit Agreement dated as of March 1, 2001 (the “Credit Agreement”) among TENET HEALTHCARE CORPORATION (the “Borrower”), the LENDERS, MANAGING AGENTS and CO-AGENTS party thereto, the SWINGLINE BANK party thereto, THE BANK OF NEW YORK, THE BANK OF NOVA SCOTIA and SALOMON SMITH BARNEY INC., as Documentation Agents, BANK OF AMERICA, N.A., as Syndication Agent, and JPMORGAN CHASE BANK, F/K/A MORGAN GUARANTY TRUST COMPANY OF NEW YORK, as Administrative Agent (the “Administrative Agent”).

W I T N E S S E T H :

WHEREAS, the parties hereto desire to amend the Credit Agreement to (i) change the conditions to borrowings and issuances or extensions of letters of credit as they relate to material adverse changes in the business of the Borrower and its Subsidiaries; (ii) reduce the maximum allowable Leverage Ratio of the Borrower and its Subsidiaries; and (iii) replace the Pricing Schedule attached to the Credit Agreement;

NOW, THEREFORE, the parties hereto agree as follows:

Section 1.  Defined Terms; References.  Unless otherwise specifically defined herein, each term used herein which is defined in the Credit Agreement has the meaning assigned to such term in the Credit Agreement.  Each reference to “hereof”, “hereunder”, “herein” an “hereby” and each other similar reference and each reference to “this Agreement” and each other similar reference contained in the Credit Agreement shall, after this Amendment becomes effective, refer to the Credit Agreement as amended hereby.

Section 2.  Amendment Of The Credit Agreement.  (a)Section 3.03 of the Credit Agreement is amended by inserting a new clause 3.03(f) to read as follows:  “(f) the Required Lenders have not provided notice to the Administrative Agent that, in their good faith determination, there has been a material adverse change since November 30, 2000 in the business, operations, properties, financial condition or prospects of the Borrower and its Subsidiaries, considered as a whole”.

(b)           Section 4.04 is amended by deleting clause (c) in its entirety.

(c)           Section 5.09 of the Credit Agreement is amended by replacing the number “3.50” with “2.50”.

(d)           The Pricing Schedule attached to the Credit Agreement is amended by replacing it with the Pricing Schedule attached hereto.  The retention in the Pricing Schedule of Pricing Levels based on a Leverage Ratio in excess of 2.50 is without prejudice to the rights of the Lending Parties in respect of the Event of Default which would exist in those circumstances under the Credit Agreement as amended hereby.

Section 3.  Representations Of Borrower.  The Borrower represents and warrants that (i) the representations and warranties of the Borrower set forth in Article 4 of the Credit Agreement will be true on and as of the Amendment Effective Date and (ii) no Default will have occurred and be continuing on such date.

Section 4.  Governing Law.  This Amendment shall be governed by and construed in accordance with the laws of the State of New York.

Section 5.  Counterparts.  This Amendment may be signed in any number of counterparts, each of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument.

Section 6.  Effectiveness.  This Amendment shall become effective on the date (the “Amendment Effective Date”) when the Administrative Agent shall have received from each of the Borrower and Lenders comprising the Required Lenders a counterpart hereof signed by such party or facsimile or other written confirmation (in form satisfactory to the Administrative Agent) that such party has signed a counterpart hereof.

2

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed by their respective authorized officers as of the day and year first above written.

TENET HEALTHCARE CORPORATION
By:	/s/ Stephen D. Farber
	Title: Chief Financial Officer
JPMORGAN CHASE BANK
By:	/s/ Jim Ely III
	Title: Managing Director
BANK OF AMERICA, N.A.
By:	/s/ Kevin Wagley
	Title: Principal
THE BANK OF NOVA SCOTIA
By:	/s/ Jon A. Burckin
	Title: Managing Director
SUNTRUST BANK
By:	/s/ W. Brooks Hubbard
	Title: Director
FLEET NATIONAL BANK
By:	/s/ Maryann S. Smith
	Title: Director

THE BANK OF NEW YORK
By:	/s/ Rebecca K. Levine
	Title: Vice President
CITICORP USA, INC.
By:
	Title:
CREDIT SUISSE FIRST BOSTON
By:	/s/ Christopher Lally
	Title: Vice President
By:	/s/ Jennifer A. Pieza
	Title: Associate
SUMITOMO MITSUI BANKING CORPORATION
By:	/s/ Al Galluzzo
	Title: Senior Vice President
UBS AG, STAMFORD BRANCH
By:	/s/ Wilfred V. Saint
	Title: Associate Director
By:	/s/ Anthony N. Joseph
	Title: Associate Director

UFJ BANK LIMITED
By:	/s/ Steve Yamada
	Title: Vice President
MERRILL LYNCH CAPITAL CORPORATION
By:
	Title:
MIZUHO CORPORATE BANK, LIMITED
By:
	Title:
CREDIT LYONNAIS NEW YORK BRANCH
By:	/s/ Charles Heideieck
	Title: Senior Vice President
PNC BANK, NATIONAL ASSOCIATION
By:	/s/ Timothy J. Hornickle
	Title: Vice President
WACHOVIA BANK, NATIONAL ASSOCIATION
By:
	Title:

KBC BANK N.V.
By:
	Title:
U.S. BANK NATIONAL ASSOCIATION
By:	/s/ Christian Stein III
	Title: Vice President
BNP PARIBAS
By:	/s/ Brock Harris
	Title: Director
HUA NAN COMMERCIAL BANK, LTD.
By:
	Title:
NATIONAL CITY BANK
By:	/s/ Roderic M. Brown
	Title: Senior Vice President
SOUTHTRUST BANK
By:
	Title:
By:
	Title:

PB CAPITAL CORPORATION
By:	/s/ Chritopher J. Ruzzi
	Title: Vice President
By:	/s/ Andrew L. Shipman
	Title: Assistant Vice President
ALLIED IRISH BANK
By:	/s/ Anthony O’Reilly
	Title: Vice President
By:	/s/ Hilary Patterson
	Title: Vice President
CHINATRUST COMMERCIAL BANK
By:
	Title:
COMERICA BANK
By:	/s/ Colleen M. Murphy
	Title: Vice President
COMMERCEBANK, N.A.
By:	/s/ George H. Bermudez
	Title: Vice President

TORONTO DOMINION (TEXAS), INC.
By:	/s/ Mark A. Baird
	Title: Vice President
BANK LEUMI USA
By:	/s/ Joung Hee Hong
	Title: Vice President
HIBERNIA NATIONAL BANK
By:	/s/ Laura Watts
	Title: Vice President
MORGAN STANLEY BANK
By:
	Title:
BANK OF IRELAND
By:
	Title:
MALAYAN BANKING BERHAD
By:	/s/ Wan Fadzmi Othman
	Title: General Manager
VAN KAMPEN PRIME RATE INCOME TRUST
By:
	Title:

PRICING SCHEDULE

The “Facility Fee Rate” and “Euro-Dollar Margin” for any day are the respective rates per annum set forth below in the applicable row under the column corresponding to the Pricing Level and Utilization that apply on such day:

Pricing Level	Level I		Level II		Level III		LevelIV		Level V		Level VI
Facility Fee Rate:
Utilization > 40%	0.500	%	0.500	%	0.500	%	0.500	%	0.500	%	0.500	%
Utilization < 40%	0.500	%	0.500	%	0.500	%	0.500	%	0.500	%	0.575	%
Euro-Dollar Margin:
Utilization > 40%	1.000	%	1.000	%	1.000	%	1.175	%	1.350	%	2.000	%
Utilization < 40%	1.000	%	1.000	%	1.000	%	1.125	%	1.275	%	1.925	%

For purposes of this Pricing Schedule, the following terms have the following meanings:

“Level I Pricing” applies during any Rate Period if, at the end of the Preceding Fiscal Quarter, the Leverage Ratio was less than 1.75 to 1.

“Level II Pricing” applies during any Rate Period if no higher Pricing Level applies and, at the end of the Preceding Fiscal Quarter, the Leverage Ratio was equal to or greater than 1.75 to 1.

“Level III Pricing” applies during any Rate Period if no higher Pricing Level applies and, at the end of the Preceding Fiscal Quarter, the Leverage Ratio was equal to or greater than 2.00 to 1.

“Level IV Pricing” applies during any Rate Period if no higher Pricing Level applies and, at the end of the Preceding Fiscal Quarter, the Leverage Ratio was equal to or greater than 2.50 to 1.

“Level V Pricing” applies during any Rate Period if no higher Pricing Level applies and, at the end of the Preceding Fiscal Quarter, the Leverage Ratio was equal to or greater than 3.00 to 1.

“Level VI Pricing” applies during any Rate Period if, at the end of the Preceding Fiscal Quarter, the Leverage Ratio was equal to or greater than 3.25 to 1.

 “Preceding Fiscal Quarter” means, with respect to any Rate Period, the most recent Fiscal Quarter ended before such Rate Period begins.

 “Pricing Level” refers to the determination of which of Level I Pricing, Level II Pricing, Level III Pricing, Level IV Pricing, Level V Pricing or Level VI Pricing applies on any day. Pricing Levels are referred to in ascending order (e.g., Level II Pricing is a higher Pricing Level than Level I Pricing).

“Rate Period” means any period from and including the 46th day of a Fiscal Quarter to and including the 45th day of the immediately succeeding Fiscal Quarter.

“Utilization” means, at any date, the percentage equivalent of a fraction (i) the numerator of which is the sum of the aggregate outstanding principal amount of Loans and Swingline Loans and the Aggregate LC Exposure, each at such date, and (ii) the denominator of which is the aggregate amount of the Commitments at such date.  If for any reason any Credit Exposure remains following termination of the Commitments, Utilization shall be deemed to be in excess of 40%.